Awiqli

News

11 blockbuster drugs to look out for in 2025

Clarivate has revealed 11 drugs due to launch in 2025 that could top $1 billion in annual sales or be clinical 'game changers' in the next five years.

News

FDA rejects Novo Nordisk’s weekly basal insulin

Novo Nordisk’s bid to provide a once-weekly basal insulin product for people with diabetes, reducing the number of injections needed, has hit a major hurdle in the US.

News

CHMP backs Novartis’ Fabhalta as first oral therapy for PNH

The March meeting of the EMA’s human medicines committee (CHMP) saw an approval recommendation for Novartis’ Fabhalta, on track to become the first oral monotherapy for ra

11 blockbuster drugs to look out for in 2025

FDA rejects Novo Nordisk’s weekly basal insulin

CHMP backs Novartis’ Fabhalta as first oral therapy for PNH

NHS staff 'feel unprepared for digital transformation'

How to meet your physicians where they are online

Editor's Picks